CTLA4 and metastatic malignant neoplasm: Demaria et al. conducted a study on mice with poorly immunogenic metastatic cancer types where the models were treated either with a single modality regimen using only anti-CTLA-4 blockade or a combination of anti-CTLA-4 and radiation therapy.